Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

Rep. Frank Pallone Jr.

BioNJ Gala Speaker Predicts 21st Century ‘Cracking of Biology Nut’; Leaders Honored

Newark, NJ, February 3, 2017 — In what has become one of the top New Jersey life sciences events, the trade organization BioNJ last night held its 24th annual dinner meeting, networking event and innovation celebration at the Hilton East Brunswick, with some 650 people in attendance, reports George N. Saliba in New Jersey Business.

Rousing speeches by the likes of life sciences icon Fred Hassan, and, separately, journalist extraordinaire Joan Lunden, underscored the order-of-magnitude progress being made in the life sciences arena. Continue reading

Pallone Holds Roundtable Discussion on President Obama’s Cancer Moonshot Initiative at Rutgers Cancer Institute of New Jersey

Pallone Moonshot Cancer 1

U.S. House Energy and Commerce Committee Ranking Member Frank Pallone (second from right) leads discussion on cancer research at Rutgers

New Brunswick, NJ, May 5 ― Congressman Frank Pallone, Jr. (NJ-06) May 3 held a roundtable discussion on President Obama’s Cancer Moonshot Initiative at the Rutgers Cancer Institute of New Jersey.

The Institute’s interim director Bruce G. Haffty, MD, researchers from the institute, officials from the U.S. Department of Health and Human Services, and cancer research advocates also participated in the discussion.

“The Rutgers Cancer Institute of New Jersey is an international leader in cutting edge cancer research and treatment,” said Pallone.  “I am proud of its contributions and can see it has an important role to play in the National Cancer Moonshot Initiative that both President Obama and Vice President Biden have been championing.” Continue reading

Vice President Biden Meets with Members of Congress Behind Medical Innovation Bills

Joe BidenWashington, DC, March 17, 2016 ― Peter Sullivan reports in The Hill that Vice President Biden met with a bipartisan group of lawmakers on Wednesday to discuss a medical innovation bill that could be the path to funding for his “moonshot” to cure cancer.

Biden met with House Energy and Commerce Committee Chairman Fred Upton (R-Mich.), ranking member Frank Pallone Jr. (D-N.J.) and Rep. Diana DeGette (D-Colo.), who are the leaders of the House’s 21st Century Cures effort.

Also at the meeting were Senate Health Committee Chairman Lamar Alexander (R-Tenn.) and ranking member Patty Murray (D-Wash.). Continue reading

National Journal Profile: It’s a Great Time to Be Frank Pallone

Frank Pallone flag

U.S. House Committee on Energy and Commerce Ranking Member Frank Pallone, Jr. (NJ-D-6)

Washington, DC, July 27, 2015 ― Frank Pallone feels he got lucky, starts Fawn Johnson’s National Journal profile on the Congressman, who represents New Jersey’s 6th Congressional District.

Pallone ascended to the top Democratic spot on the House Energy and Commerce Committee just before Republicans began reaching out to Democrats to salvage their disastrous start to the current session.  And now, with the GOP looking to mend fences, Pallone says he’s in position to accomplish what few lawmakers currently can: actually make laws.

“I made it my business that I wanted to work with the Republicans,” Pallone said in the interview with Johnson.  “If not, how are we ever going to pass any legislation?”  Continue reading

Rep. Pallone Announces Biomedical Research Funding Critical to New Jersey with House Passage of 21st Century Cures

Frank Pallone flag

U.S. Rep. Frank Pallone, Jr. (D-6) serves as Ranking Member of the House Committee on Energy and Commerce

Washington, DC, July 13, 2015 ― With the House of Representatives’ passage of the 21st Century Cures Act on Friday, Congressman Frank Pallone, Jr. (NJ-06) announced biomedical research funding in the legislation to support progress toward treatments for rare diseases.

Congressman Pallone has played an integral role in leading the bill through the House as both a sponsor of the legislation and as the Ranking Member of the Energy and Commerce Committee.

The legislation provides a National Institutes of Health (NIH) funding boost to New Jersey and the state stands to benefit as a leader in drug manufacturing and biomedical research.  The bill passed the House by a 344 to 77 vote.

“21st Century Cures is a good bill for patients around the country and stands to be a very good bill for the State of New Jersey.  I am glad that our hard bipartisan work has paid off in the bill’s passage,” said Congressman Pallone. Continue reading